Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Learn more about the possibilities of this page

Marinomed Biotech AG Stock

Price

Target price

/ Stuttgart Stock Exchange WKN: A2N9MM / Name: Marinomed Biotech / Stock / ? /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

Financial data and news for Marinomed Biotech

sharewise wants to provide you with the best news and tools for Marinomed Biotech, so we directly link to the best financial data sources.

Financials

News

Broker

News

EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration

EQS-News: Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration

0

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration

0

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administrationPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

0

EQS-News: Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation TherapyPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

EQS-News: Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy

EQS-News: Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy

0

EQS-News: Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding MarketPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-News: Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market

EQS-News: Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market

0

EQS-News: Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology

EQS-News: Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology

EQS-News: Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology

0

EQS-News: Marinomed secures financing through successful capital increase

EQS-News: Marinomed secures financing through successful capital increase

EQS-News: Marinomed secures financing through successful capital increase

0

Marinomed Biotech Announces Capital increase with subscription rightsPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Marinomed Biotech Announces Capital increase with subscription rights

Marinomed Biotech Announces Capital increase with subscription rights

0

EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 millionPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million

EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million

0